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AIMS OF THE STUDY 
 
1. To study the liver function tests in congestive cardiac failure. 
 
2. To observe any differences in liver function tests with the etiology of 
congestive cardiac failure. 
 
3. To study the relationship between liver function test and remission and 
exacerbation of congestive cardiac failure. 
 
4. To study whether liver function tests can be used as a prognostic      
indicator in cases of congestive cardiac failure. 
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INTRODUCTION 
 
          The liver has been called the custodian of milieu interior [5]. So  
any liver disorders will have far reaching consequences on body’s  
homeostasis. Also, numerous pathologies of other systems can affect liver.  
          Both acute and chronic heart failure may result in abnormalities of liver.  
Liver receives 25% of cardiac output, that a fall in cardiac output will result in  
hepatic hypoperfusion. Liver has the capacity to withstand changes in blood  
flow by vasoactive mechanisms and oxygen extraction from blood. However  
     when critical levels are reached, hepatic injury ensues[16]. 
          Both Right and left sided heart failure can result in liver injury. In right  
-sided heart failure, elevation of right heart pressure resulting in raised pressure  
in hepatic sinusoids, hepatic congestion and liver cell hypoxia. In left sided  
heart failure, decreased cardiac output results in hepatic hypo perfusion and  
hypoxia. The common pathway is centrilobular hepatocellular necrosis. Zone 3  
of the liver lobule is most vulnerable to hypoxic injury due organization of  
hepatic blood flow. 
         In this study, the effects of congestive cardiac failure on liver and its  
function is analyzed in 75 patients compared with 20 healthy individuals.  
Various etiologies of congestive cardiac failure have been included and  
 3
compared, based on their effects on liver functions. Remissions and  
exacerbations have been tracked on the 7th day and the variations of liver  
function have been recorded and an attempt has been made to find whether liver  
function tests can be used as prognostic indicators of congestive cardiac failure. 
         Understanding anatomy and functions of liver, liver enzymes, causes and  
various forms of congestive cardiac failure and their manifestations, pathology  
of liver in heart failure are needed before evaluating abnormalities of liver  
function tests in congestive heart failure. 
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REVIEW OF LITERATURE 
 
 
ANATOMY AND FUNTIONS OF LIVER 
                   
                          Liver is the largest organ of the body weighing around 1.5kg. 
The size and shape of the liver vary and generally match the general body 
shape—long and lean or squat and square. The liver is located in the right upper 
quadrant of the abdomen under the right lower rib cage against the diaphragm 
and projects for a variable extent into the left upper quadrant. The liver is held 
in place by ligamentous attachments to the diaphragm, peritoneum, great 
vessels, and upper gastrointestinal organs.  
 
                           The liver has dual blood supply. The portal vein brings blood 
from the gut and hepatic artery supplies arterial blood. Hepatic vein drains the 
liver into inferior vena cava. Porta hepatis is fissure through which vessels enter 
liver where, Portal vein and hepatic artery divides into branches to right and left 
lobes. Similarly right and left hepatic ducts join here to form common hepatic 
duct. Hepatic nerve plexus derives its supply from sympathetic chain T7-T11, 
left and right vagus nerve and right phrenic nerve. Lymphatic drainage is into 
small group of glands near porta hepatis. Liver receives 1500ml of blood per 
minute, mainly through portal vein and 25% through hepatic artery. 
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FUNCTIONAL ANATOMY: 
                              The majority of cells in the liver are hepatocytes, which 
constitute two-thirds of the mass of the liver. The remaining cell types are 
Kupffer cells (reticuloendothelial cells), stellate (Ito or fat-storing) cells, 
endothelial cells and blood vessels, bile ductular cells, and supporting structures. 
In light microscopy, the liver appears to be organized in lobules, with portal areas 
at the periphery and central veins in the center of each lobule. 
                              However, from a functional point of view, the liver is 
organized into acini, with both hepatic arterial and portal venous blood entering 
the acinus from the portal areas (zone 1) and then flowing through the sinusoids 
to the terminal hepatic veins (zone 3); the intervening hepatocytes constitute zone 
2.  
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The advantage of viewing the acinus as the physiologic unit of the liver is that it 
helps to explain the morphologic patterns and zonality of many vascular and 
biliary diseases not explained by the lobular arrangement.  
 
                                  Portal areas of the liver consist of small veins, arteries, bile 
ducts, and lymphatics organized in a loose stroma of supporting matrix and small 
amounts of collagen. Blood flowing into the portal areas is distributed through 
the sinusoids, passing from zone 1 to zone 3 of the acinus and draining into the 
terminal hepatic veins ("central veins"). Hence zone 3 of the liver is vulnerable to 
hypoxic injury. Secreted bile flows in the opposite direction, in a countercurrent 
pattern from zone 3 to zone 1. The sinusoids are lined by unique endothelial cells 
that have prominent fenestrae of variable size, allowing the free flow of plasma 
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but not cellular elements. The plasma is thus in direct contact with hepatocytes in 
the space of Disse.  
 
                               Hepatocytes have distinct polarity. The basolateral side of the 
hepatocyte lines the space of Disse and is richly lined with microvilli; it 
demonstrates endocytotic and pinocytotic activity, with passive and active uptake 
of nutrients, proteins, and other molecules. The apical pole of the hepatocyte 
forms the cannicular membranes through which bile components are secreted. 
The canniculi of hepatocytes form a fine network, which fuses into the bile 
ductular elements near the portal areas. 
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                               Kupffer cells usually lie within the sinusoidal vascular space 
and represent the largest group of fixed macrophages in the body. The stellate 
cells are located in the space of Disse but are not usually prominent unless 
activated, when they produce collagen and matrix. White blood cells can migrate 
through or around endothelial cells into the space of Disse and from there to 
portal areas, where they can return to the circulation through lymphatics. 
                                                 
1. hepatic artery 2.bile duct 4. portal vein. 
                               The relative functions of cells in the periphery of acini, zone 3 
are different from those of cells in zone 1(periportal). Kreb’s cycle enzymes are 
found highest in Zone 1. Glutamic synthetase is found in perivenous cells. Zone3 
is vulnerable to hypoxic insult. Congestive cardiac failure affects zone 3 of the 
liver resulting in characteristic features.    
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FUNCTIONS OF THE LIVER: 
                                  Hepatocytes perform numerous and vital roles in 
maintaining homeostasis and health.  
      Synthetic functions:                 
                                  These functions include the synthesis of most essential 
serum proteins (albumin, carrier proteins, coagulation factors 2,7,9 and 10 , many 
hormonal and growth factors), the production of bile and its carriers (bile acids, 
cholesterol, lecithin, phospholipids). 
      Metabolism:                           
                                    The regulation of nutrients (glucose, glycogen, lipids, 
cholesterol, amino acids) such as uptake of glucose after a meal, aminoacids used 
for synthetic functions, production of very low density lipoproteins, metabolism 
of high and low density lipoproteins and conjugation of lipophilic compounds  
       Excretory functions:  
                                    Liver metabolises bilirubin, bile salts, many drugs and 
alcohol 
        Storage functions: 
                                    Storage of vitamins B12, A,D, Iron and Copper. 
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       Reticulo-endothelial function: 
                                   Liver acts as a microbe barrier for the portal venous blood 
from the gut through kupffer and other cells. It also detoxifies toxins 
       Heat production:  
                                   Liver carries out various anabolic and catabolic reactions. 
One of by- products of these reactions is heat, helping in thermostasis. 
LIVER FUNCTION TESTS: 
                                     Measurement of these activities to assess liver function is 
complicated by the multiplicity and variability of these functions. The most 
commonly used liver "function" tests are measurements of serum bilirubin, 
albumin, and prothrombin time.  
                                      The serum bilirubin level is a measure of hepatic 
conjugation and excretion, and the serum albumin level and prothrombin time are 
measures of protein synthesis. Abnormalities of bilirubin, albumin, and 
prothrombin time are typical of hepatic dysfunction. Frank liver failure is 
incompatible with life, and the functions of the liver are too complex and diverse 
to be sub served by a mechanical pump; dialysis membrane; or concoction of 
infused hormones, proteins, and growth factors    
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Tests Based on Detoxification and Excretory Functions 
1. Serum Bilirubin, a breakdown product of the porphyrin ring of heme-
containing proteins, is found in the blood in two fractions—conjugated and 
unconjugated. The unconjugated fraction, also termed the indirect fraction, is 
insoluble in water and is bound to albumin in the blood. The conjugated (direct) 
bilirubin fraction is water soluble and can therefore be excreted by the kidney. 
When measured by the original van den Bergh method, the normal total serum 
bilirubin concentration is <17 micro mol/L (1 mg/dL). Up to 30%, or 5.1 micro 
mol/L (0.3 mg/dL), of the total is direct-reacting (or conjugated) bilirubin. 
                Elevation of the unconjugated fraction of bilirubin is rarely due to liver 
disease. An isolated elevation of unconjugated bilirubin is seen primarily in 
hemolytic disorders and in a number of genetic conditions such as Crigler-Najjar 
and Gilbert's syndromes .Isolated unconjugated hyperbilirubinemia (bilirubin 
elevated but <15% direct) should prompt a workup for hemolysis In the absence 
of hemolysis. 
               In contrast, conjugated hyperbilirubinemia almost always implies liver 
or biliary tract disease. The rate-limiting step in bilirubin metabolism is not 
conjugation of bilirubin, but rather the transport of conjugated bilirubin into the 
bile canaliculi. Thus, elevation of the conjugated fraction may be seen in any 
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type of liver disease. In most liver diseases, both conjugated and unconjugated 
fractions of the bilirubin tend to be elevated.  
2. Serum Enzymes 
The liver contains thousands of enzymes, some of which are also present in the 
serum in very low concentrations. These enzymes have no known function in the 
serum and behave like other serum proteins. They are distributed in the plasma 
and in interstitial fluid and have characteristic half-lives, usually measured in 
days. Very little is known about the catabolism of serum enzymes, although they 
are probably cleared by cells in the reticuloendothelial system. The elevation of a 
given enzyme activity in the serum is thought to primarily reflect its increased 
rate of entrance into serum from damaged liver cells. 
Serum enzyme tests can be grouped into three categories: (1) enzymes whose 
elevation in serum reflects damage to hepatocytes, (2) enzymes whose elevation 
in serum reflects cholestasis, and (3) enzyme tests that do not fit precisely into 
either pattern. 
         A. Enzymes that Reflect Damage to Hepatocytes 
The aminotransferases (transaminases) are sensitive indicators of liver cell injury 
and are most helpful in recognizing acute hepatocellular diseases such as 
hepatitis. They include the aspartate aminotransferase (AST) and the alanine 
aminotransferase (ALT). AST is found in the liver, cardiac muscle, skeletal 
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muscle, kidneys, brain, pancreas, lungs, leukocytes, and erythrocytes in 
decreasing order of concentration. ALT is found primarily in the liver. The 
aminotransferases are normally present in the serum in low concentrations. These 
enzymes are released into the blood in greater amounts when there is damage to 
the liver cell membrane resulting in increased permeability. Liver cell necrosis is 
not required for the release of the aminotransferases, and there is a poor 
correlation between the degree of liver cell damage and the level of the 
aminotransferases. Thus, the absolute elevation of the aminotransferases is of no 
prognostic significance in acute hepatocellular disorders. 
Any type of liver cell injury can cause modest elevations in the serum 
aminotransferases. Levels of up to 300 U/L are nonspecific and may be found in 
any type of liver disorder. Minimal ALT elevations in asymptomatic blood 
donors rarely indicate severe liver disease; studies have shown that fatty liver 
disease is the most likely explanation. Striking elevations—i.e., 
aminotransferases > 1000 U/L—occur almost exclusively in disorders associated 
with extensive hepatocellular injury such as (1) viral hepatitis, (2) ischemic liver 
injury (prolonged hypotension or acute heart failure), or (3) toxin- or drug-
induced liver injury. 
The pattern of the aminotransferase elevation can be helpful diagnostically. In 
most acute hepatocellular disorders, the ALT is higher than or equal to the AST. 
An AST:ALT ratio > 2:1 is suggestive while a ratio > 3:1 is highly suggestive of 
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alcoholic liver disease. The AST in alcoholic liver disease is rarely >300 U/L and 
the ALT is often normal. A low level of ALT in the serum is due to an alcohol-
induced deficiency of pyridoxal phosphate. 
The aminotransferases are usually not greatly elevated in obstructive jaundice. 
One notable exception occurs during the acute phase of biliary obstruction caused 
by the passage of a gallstone into the common bile duct. In this setting, the 
aminotransferases can briefly be in the 1000–2000 U/L range. However, 
aminotransferase levels decrease quickly, and the liver function tests rapidly 
evolve into one typical of cholestasis. 
      B. Enzymes that Reflect Cholestasis 
The activities of three enzymes—alkaline phosphatase, 5'-nucleotidase, and -
glutamyl transpeptidase (GGT)—are usually elevated in cholestasis.                   
Elevation of liver-derived alkaline phosphatase is not totally specific for 
cholestasis, and a less than threefold elevation can be seen in almost any type of 
liver disease. Alkaline phosphatase elevations greater than four times normal 
occur primarily in patients with cholestatic liver disorders, infiltrative liver 
diseases such as cancer and amyloidosis, and bone conditions characterized by 
rapid bone turnover (e.g., Paget's disease). In bone diseases, the elevation is due 
to increased amounts of the bone isoenzymes. In liver diseases, the elevation is 
almost always due to increased amounts of the liver isoenzyme. 
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If an elevated serum alkaline phosphatase is the only abnormal finding in an 
apparently healthy person, or if the degree of elevation is higher than expected in 
the clinical setting, identification of the source of elevated isoenzymes is helpful. 
This problem can be approached in several ways. First, and most precise, is the 
fractionation of the alkaline phosphatase by electrophoresis.  
                   The second approach is based on the observation that alkaline 
phosphatases from individual tissues differ in susceptibility to inactivation by 
heat. The finding of an elevated serum alkaline phosphatase level in a patient 
with a heat-stable fraction strongly suggests that the placenta or a tumor is the 
source of the elevated enzyme in serum. Susceptibility to inactivation by heat 
increases, respectively, for the intestinal, liver, and bone alkaline phosphatases, 
bone being by far the most sensitive 
Tests that Measure Biosynthetic Function of the Liver 
       A. Serum Albumin: Serum albumin is synthesized exclusively by 
hepatocytes. Serum albumin has a long half-life: 18–20 days, with ~4% degraded 
per day. Because of this slow turnover, the serum albumin is not a good indicator 
of acute or mild hepatic dysfunction; only minimal changes in the serum albumin 
are seen in acute liver conditions such as viral hepatitis, drug-related hepatoxicity, 
and obstructive jaundice. In hepatitis, albumin levels < 3 g/dL should raise the 
possibility of chronic liver disease. Hypoalbuminemia is more common in 
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chronic liver disorders such as cirrhosis and usually reflects severe liver damage 
and decreased albumin synthesis. One exception is the patient with ascites in 
whom synthesis may be normal or even increased, but levels are low because of 
the increased volume of distribution. However, hypoalbuminemia is not specific 
for liver disease and may occur in protein malnutrition of any cause, as well as 
protein-losing enteropathies, nephrotic syndrome, and chronic infections that are 
associated with prolonged increases in levels of serum interleukin 1 and/or tumor 
necrosis factor, cytokines that inhibit albumin synthesis. Serum albumin should 
not be measured for screening in patients in whom there is no suspicion of liver 
disease.  
        B. Serum Globulins 
Serum globulins are a group of proteins made up of Gamma globulins 
(immunoglobulins) produced by B lymphocytes and Alpha and Beta globulins 
produced primarily in hepatocytes. Gamma Globulins are increased in chronic 
liver disease, such as chronic hepatitis and cirrhosis. In cirrhosis, the increased 
serum gamma globulin concentration is due to the increased synthesis of 
antibodies, some of which are directed against intestinal bacteria. This occurs 
because the cirrhotic liver fails to clear bacterial antigens that normally reach the 
liver through the hepatic circulation. 
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Increases in the concentration of specific isotypes of Gamma globulins are often 
helpful in the recognition of certain chronic liver diseases. Diffuse polyclonal 
increases in IgG levels are common in autoimmune hepatitis; increases >100% 
should alert the clinician to this possibility. Increases in the IgM levels are 
common in primary biliary cirrhosis, while increases in the IgA levels occur in 
alcoholic liver disease. 
          C. Coagulation Factors 
With the exception of factor VIII, the blood clotting factors are made exclusively 
in hepatocytes. Their serum half-lives are much shorter than albumin, ranging 
from 6 h for factor VII to 5 days for fibrinogen. Because of their rapid turnover, 
measurement of the clotting factors is the single best acute measure of hepatic 
synthetic function and helpful in both the diagnosis and assessing the prognosis 
of acute parenchymal liver disease. Useful for this purpose is the serum 
prothrombin time, which collectively measures factors II, V, VII, and X. 
Biosynthesis of factors II, VII, IX, and X depends on vitamin K. The 
prothrombin time may be elevated in hepatitis and cirrhosis as well as in 
disorders that lead to vitamin K deficiency such as obstructive jaundice or fat 
malabsorption of any kind.  
 
 
 18
 
CONGESTIVE CARDIAC FAILURE 
                    
                   Congestive cardiac failure is defined as inability of heart to 
maintain an output, at rest or during exercise, necessary for the metabolic needs 
of the body and inability to receive blood into ventricular cavity at low pressure 
during diastole.[18] 
                   In our study, patients were included as having congestive cardiac 
failure, if they had at least one Major and Minor criteria of Framingham 
criteria. [19] 
FRAMINGHAM CRITERIA 
MAJOR 
1. Paroxysmal nocturnal Dyspnea 
2. Neck vein  distension 
3. Crackles 
4. Cardiomegaly 
5. Acute pulmonary edema 
6. S3 gallop 
7. Increased venous pressure (16cm H20) 
8. Positive hepatojugular reflex 
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      MINOR 
1. Extremity edema 
2. Night cough 
3. Dyspnea on exertion 
4. Hepatomegaly 
5. Pleural effusion 
6. Vital capacity reduced by one third to normal 
7. Tachycardia > 120/ min 
8. Weight loss over 4.5kg over 5 days treatment. 
                               Heart failure may be described as systolic, diastolic, high 
output low output, acute or chronic and right or left sided. These separations blur 
in the course of the disease. 
 
               CAUSES OF CONGESTIVE CARDIAC FAILURE:[20] 
Depressed Ejection Fraction (<40%)  
  Coronary artery disease 
 
  Nonischemic dilated cardiomyopathy 
 
  Myocardial infarction 
 
  Toxic/drug-induced damage 
 
  Myocardial ischemia 
 
  Infiltrative disorders 
 
  Chronic pressure overload/ Familial/genetic disorders 
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Hypertension 
 
Metabolic disorder 
 
Viral 
 
Obstructive valvular disease 
 
Chronic volume overload 
 
Chagas' disease 
 
Disorders of rate and rhythm 
 
Intracardiac (left-to-right) shunting 
 
Chronic bradyarrhythmias 
 
Preserved Ejection Fraction (>40–50%)  
  Pathological hypertrophy 
 
  Restrictive cardiomyopathy 
 
  Primary(hypertrophic cardiomyopathy) 
 
  Infiltrative disorders (amyloidosis, sarcoidosis) 
 
  Secondary (hypertension) 
     Fibrosis 
 
     Aging 
 
   Storage diseases (hemochromatosis) 
 
Pulmonary Heart Disease  
  Pulmonary vascular disorders 
 
  Cor pulmonale 
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High-Output States  
 
Metabolic disorders                                      
Excessive blood-flow requirements 
  Nutritional disorders (beriberi) 
 
  Chronic anemia 
 
  Systemic arteriovenous shunting 
 
Thyrotoxicosis 
 
Precipitating factors: 
                               In evaluating heart failure, it is also important to identify 
precipitating factors. [21] 
1. Anemia 
2. Pregnancy 
3. Infections 
4. Thyrotoxicosis 
5. Arrythmia 
6. Infective endocarditis 
7. systemic hypertension 
8. metabolic and physical changes 
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Forms of heart failure: 
Systolic Versus Diastolic Failure 
                                This classification relates to whether the principal 
abnormality is the inability to contract normally and expel sufficient blood 
(systolic failure) or to relax and fill normally (diastolic failure). The major 
clinical manifestations of systolic failure relate to an inadequate cardiac output 
with weakness, fatigue, reduced exercise tolerance and other symptoms of 
hypoperfusion, while in diastolic failure they relate principally to an elevation of 
filling pressures. In many patients, abnormalities of contraction and relaxation 
coexist.  
                                 Diastolic heart failure may be caused by increased resistance 
to ventricular inflow and reduced ventricular diastolic capacity (constrictive 
pericarditis and restrictive, hypertensive, and hypertrophic cardiomyopathy), 
impaired ventricular relaxation (acute myocardial ischemia, hypertrophic 
cardiomyopathy), and myocardial fibrosis and infiltration. 
High Output Versus Low Output Heart Failure 
                                  Low output heart failure occurs secondary to ischemic heart 
disease, hypertension, dilated cardiomyopathy, and valvular and pericardial 
disease. High output heart failure occurs in hyperthyroidism, anemia, pregnancy, 
arteriovenous fistulas, beriberi, and Paget’s disease. 
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Acute Versus Chronic Heart Failure 
                                  The prototype of acute heart failure is the patient who is 
entirely well but who suddenly develops a large myocardial infarction or rupture 
of a cardiac valve. Chronic heart failure is typically observed in patients with 
dilated cardiomyopathy or multivalvular heart disease that develops or progresses 
slowly. Acute heart failure is usually largely systolic and the sudden reduction in 
cardiac output often results in systemic hypotension without peripheral edema. In 
chronic heart failure, arterial pressure tends to be well maintained until very late 
in the course, but there is often accumulation of peripheral edema. 
Right Sided Versus Left Sided Heart Failure 
                                  Patients in whom the left ventricle is mechanically 
overloaded (e.g., aortic stenosis) or weakened (e.g., post myocardial infarction) 
develop dyspnea and orthopnea as a result of pulmonary congestion, a condition 
referred to as left sided heart failure. In contrast, when the underlying 
abnormality affects the right ventricle primarily (e.g., pulmonic stenosis or 
pulmonary hypertension), symptoms resulting from pulmonary congestion are 
less common, and edema, congestive hepatomegaly, and systemic venous 
distention, are more prominent. However, when heart failure has existed for 
months or years, biventricular failure usually results. For example, patients with 
long standing aortic valve disease or systemic hypertension may have ankle 
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edema, congestive hepatomegaly, and systemic venous distention late in the 
course of their disease.  
Backward Versus Forward Heart Failure 
                           The concept of backward heart failure contends that in heart 
failure, one or the other ventricle fails to discharge its contents or fails to fill 
normally. As a consequence, the pressures in the atrium and venous system 
behind the failing ventricle rise, and retention of sodium and water occurs as a 
consequence of the elevation of systemic venous and capillary pressures and the 
resultant transudation of fluids into the interstitial space. In forward failure, salt 
and water retention is a consequence of diminished renal perfusion and excessive 
proximal tubular sodium re-absorption and of excessive distal tubular re- 
absorption through activation of the renin-angiotensin-aldosterone system.  
Irrespective of the type of failure, Congestive heart failure affects liver 
structurally and various functions of liver. 
 In this study, changes in liver function tests in various causes of congestive 
cardiac failure such as rheumatic, congenital, ischemic, cardiomyopathic, cor 
pulmonale and hypertensive heart diseases are noted in 75 patients presenting 
with heart failure and compared with themselves and a control of 20 apparently 
healthy individuals. Also, the patients are tracked for 7 days, liver function tests 
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are performed again and compared with admission values, to note whether 
remission or exacerbation has any impact on LFTs. 
Review of other Studies and journals: 
          One of the most common manifestations of congestive heart   failure is 
enlargement of the liver. This fact has led several investigators such as Jollife; 
Robertson [1] [2]  [3]  [4]   to study liver function tests in an attempt to evaluate 
hepatic dysfunction in congestive heart failure.  
                   Historically, the first association of liver pathology and congestive 
heart failure was noted by Kiernan [6] who described the "nutmeg liver." Seventy 
eight years later Mallory [7] described the typical microscopic appearance of 
central congestion with focal necrosis. Other authors pointed out the fatty 
changes [8] and the compression of capillaries by edema fluid accumulated 
between the liver cell cords and capillaries [9] [10]. 
                    The three main theories of the pathogenesis of the altered liver 
anatomy   are: infection,[7]. mechanical compression [11]  [12] and hypoxia 
with secondary nutritional deficiency [13] [14] [15] The deficiency in oxygen 
supply to liver cells in heart failure seems to be due not only to the slowing of 
blood flow through the liver but even more so to arterial unsaturation resulting 
from pulmonary lesions. This was stressed by Rich [14] and others [13] [22] [15] 
who pointed out that the jaundice of heart failure is especially apt to develop 
following pulmonary infarction. Ingelfinger's [23] studies of bromsulfalein 
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removal rates by means of hepatic vein catheterization, and the studies of blood 
flow to other organs in congestive heart failure'5' 16, 67, 68, 71, 97 make it 
reasonable to assume that there is a decrease in blood flow to the liver in the 
presence of cardiac decompensation. 
             From the Medical Division of the Montefiore Hospital, there is other 
evidence for impaired liver function in congestive heart failure. Hepatic fibrosis 
has been found three times as great in patients with heart failure as in patients 
without heart failure.[24] [35] [26]. More significantly, central fibrosis so 
common in decompensated cardiac patients, did not occur at all in patients who 
were not in heart failure.  
              Hyperbilirubinemia has been found in patients who were in severe 
chronic heart failure. Jolliffe[37] and Cantarow[6] noted that bromsulfalein was 
not cleared from the blood at a normal rate in the presence of heart failure. Blood 
cholesterol levels do not seem to be altered by circulatory embarrassment.[40]                          
Gravin [25] in 1943 observed 35 cases of cardiac cirrhosis in 790 autopsy cases 
in whom heart failure was chief cause of death.The consensus is that there is a 
severe aberration in liver function in association with a failing heart. 
                S.Sherlock[43] described the clinical and biochemical features of zone 
3 necrosis in patients with heart failure. 
               Killip T. Payne in 1960 [ 38] described massive elevation of serum 
transaminases level secondary to cardiogenic shock. 
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Mechanism of liver injury in congestive cardiac failure: 
Congestive heart failure causes: 
1. Decreased hepatic blood flow 
2. Increased hepatic venous pressure leading to edema of the sinusoids and 
atrophy of hepatocytes. 
3. Decreased arterial saturation which could result in hepatocellular 
hypoxia.[39] 
Single most important factor is Hypoxia of liver cells resulting in centrilobular 
necrosis (zone3).[44] Also ,in heart failure passive congestion of liver results due 
to increased venous pressure transmitted to small hepatic veins that drain 
Acini[42]. 
 
Microscopic studies reveled increased pressure can cause atrophy zone 3 
hepatocytes.[45]. In addition, elevated venous pressure results in sinusoidal 
congestion enlargement of sinusoidal fenestrae , through which protein rich fluid 
then enters into the space of disse. [50]. The resulting perisinusoidal edema may 
impair diffusion of oxygen and nutrients into the hepatocytes.[45] 
 
Excess fluid in the space of disse normally drains into hepatic lymphatics, but 
when lymph formation exceeds the capacity of the lymphatics, high protein fluid 
exudes from the surface of the liver into the peritoneal cavity and the typical high 
protein ascities of heart failure develops [51].  
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In the chronic hepatic congestion, fibrosis may develop in perivenular area ,zone 
3 and space of disse and further impair the diffusion of oxygen and nutrients from 
blood to hepatocytes. The fibrosis varies from one region of the liver to the other. 
This variability may be partly explained by the fibrogenic effects of focal thrombi 
within the sinusoidal hepatic venules and portal veins that are a consequence of 
chronic vascular stasis [47]. 
 
Passive congestion alone does not seem to be sufficient to cause 
significant hepatic necrosis, decreased hepatic blood flow is also necessary [42]. 
This conclusion is supported by the observation of S.Sherlock [43], of the lack of 
correlation between right atrial pressure and the degree of zone 3 necrosis in 
patients with congestive heart failure. Moreover, significant zone 3 necrosis 
caused by acute left sided heart failure has been documented in the complete 
absence of right sided heart failure, a finding that suggests cardiac output is the 
principal determinant of hepatic ischemia [47]. However passive congestion 
seems to be an important co factor in most cases of clinical apparent hepatic 
ischemia. In a recent study all patients with the clinical diagnosis of ischemic 
hepatitis were found to have clinically significant cardiac disease and 94% have 
right sided heart failure [ 48]. 
                   In another study, ischemic hepatitis in patients with chronic 
respiratory disease and patients with congestive heart failure, all but one patient 
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with ischemic hepatitis had a central venous pressure above 10 cmH20.[49]. 
These findings suggests that chronic passive congestion major role in sensitizing 
the liver to hemodynamic and hypoxic insults 
 
Hepatic ischemia: 
                 Hepatic ischemia like ischemia involving other organs results from the 
imbalance between hepatic oxygen supply and demand. Because of the metabolic 
rate of the liver is relatively constant, oxygen supply, not demand is principal 
determinant of hepatic ischemia [52]. Hepatic oxygen delivery is the function of 
both the oxygen content of the blood and total hepatic blood flow. 
 
                 Systemic hypoxia alone is usually insufficient to cause significant 
Hepatic injury [53][54],but severe hypoxemia was reported to cause hepatic 
injury in a patient with obstructive sleep apnea[55] 
And in a series of patients with exacerbation of chronic respiratory failure usually, 
in the setting of passive hepatic congestion resulting from right sided heart 
failure.[49]. 
           
                 Most critical factor in hepatic ischemia is total hepatic blood flow. 
Numerous studies have shown that hepatic blood flow is determined primarily by 
cardiac output and that the splanchnic bed receives relatively constant 25% of the 
cardiac output [56] The liver has a dual blood supply receiving about 17 – 34% 
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of the blood flow from the hepatic artery and 66 – 83 % via the low pressure 
portal vein, in which the oxygen saturation is   relatively high [57] [58], thus 
much of its oxygen supply from the portal vein. 
 
                If patients cannot increasse their cardiac output there is a fall in 
splanchnic blood flow with exercise and a reduced hepatic blood flow, the 
oxygen requirement of the liver does not change and the oxygen extraction 
increases[56] [59]. In the resting state, increased extraction of oxygen by 
hepatocytes compensates for the reduction of hepatic blood flow. However, under 
situations of systemic stress, such as sepsis or increased physical activity in 
which the cardiac output cannot increased to supply extra hepatic metabolic 
demands and the hepatic and splanchnic perfusion falls. Hepatic oxygen 
extraction is often unable to increase above an already elevated baseline, and 
hepatocellular hypoxia results, especially in zone3 of the hepatic acini.[51]. 
 
  Data from in vitro and animal models suggest that because of their high 
metabolic rate, hepatocytes are vulnerable to hypoxia at physiological 
temperatures than other cell types in liver such as kupffer cells, sinusoidal 
endothelial cells and biliary epithelial cells.[60] 
 
Furthermore, nutritional status has an important influence on hepatic 
cellular sensitivity to hypoxia. Fasted rats appear less prone than fed rats to 
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hepatic ischemia, possibly because their diminished glycogen stores provides less 
substrate for anaerobic glycolysis, so that the intra cellular production of lactic 
acid is decreased.[61]. The cellular mechanism of ischemic injury, which occurs 
when hepatocytes injured appears to be related to a disruption of mitochondrial 
respiration, depletion of adenosine triphosphate rise in levels of intracellular 
calcium and activation of cellular proteases.[62] [66] 
 
Further contributing hepatic damage under these conditions is reperfusion 
injury which occurs when hepatocytes injured by ischemia are exposed to oxygen. 
Reperfusion injury is mediated by generation of free radicals, causing injury 
through lipid peroxidation.[60] 
 
Within injured hepatocytes, mitochondria generate toxic oxygen species 
from reduced electron carriers. In addition, ischemia promotes the conversion of 
cytosolic xanthine dehydrogenase to xanthine oxidase which results in turn in 
production of superoxide and hydrogen peroxide from accumulated xanthine.[63]. 
In addition to the direct toxic effects of reactive oxygen species, ischemia and 
reperfusion induce the transcription of multiple genes in the hepatocytes via 
transcription factors, heat shock factor and nuclear factors, the product of these 
genes, including various cytokines, may contribute to hepato cellular injury [64].  
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  PATHOLOGY OF LIVER IN CONGESTIVE CARDIAC FAILURE 
Macroscopic features: 
                          The liver in congestive heart failure is enlarged and purple in 
colour with rounded edges. At autopsy, a cut section usually shows the nutmeg 
appearance associated with venous distension [43]; regular deep brown 
centrilobular zones alternating yellow or pale tan periportal zones. When cardiac 
sclerosis is present, the capsular surface is pitted and granular, on the cut surface; 
poorly circumscribed areas of parenchymal granularity or nodularity emerge 
from periportal zones, the nodules being less than 1-2mm in diameter. This 
picture differs from true cirrhosis because of the very small size of nodules, their 
non uniform distribution, poor circumscription and their origin from periportal 
regions. 
 
 
a "nutmeg" liver seen with chronic passive congestion of the liver 
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Microscopic features:  
     
                Heart failure may cause the histological changes of passive congestion 
and centrilobular necrosis but hepatic morphology may be normal. In a study 
presented in American heart journal, among 75 patients with liver failure, 47 had 
normal liver biopsy [67]. With mild congestion due to an elevated venous pressure, 
centrilobular hepatocytes become compressed and atrophic and the adjacent 
sinusoids are engorged with blood. 
If there has not been severe or chronic congestion, little else is seen [68]. With 
increasing congestion more marked hepatocellular compression with atrophy is 
seen wit an extension further from the central veins. Increased brown pigment in 
the centrilobular liver cells is a consistent finding. 
                
                 With increasing congestion centrilobular necrosis increases and fibrosis 
develops bridging central veins [70]. However, centrilobular necrosis can occur in 
severe heart failure without hypotension or shock [71] suggesting that it is a low 
cardiac output, causing decreased blood flow and parenchymal hypoxia which is 
main prerequisite for centrilobular necrosis.[ 72]. Shock is an extreme form of low 
cardiac output state. 
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NORMAL LIVER 
 
Centrilobular necrosis in Heart failure may be associated with an inflammatory 
reaction consisting of polymorphonuclear leukocytes or lymphocytes and plasma 
cells, and this picture may depend on the duration of ischemia. Cardiac sclerosis 
consists of fibrosis of central veins and at the centrilobular region, with or without 
bridging to other central veins or portal tracts. In one study cardiac sclerosis was 
the most common form of hepatic fibrosis, occurring in 48% of the cases[79]. 
 
                 Regenerative hyperplasia may be seen in peripheral zones, the 
parenchyma showing a variable increase in the number of hepatocytes within the 
liver cell plates. In most cases plate thickening alone, “Twinning” of liver cells 
occur, with three to five cells forming the plates. Affected cells are often enlarged 
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with a pale cytoplasm and enlarged and pleomorphic nuclei. Nodular regenerative 
hyperplasia has been found in a small number of cases. 
 
                 Cardiac cirrhosis appears to be relatively uncommon and can be 
considered as a progression from cardiac cirrhosis. Central- central and central- 
portal fibrosis and fibrous scars adjacent to parenchyma showing early nodularity, 
are the main histological findings. 
Passive congestion (Passive hyperemia) (liver). 
 
 
                     Passive congestion of the liver. (H&E, ob. x10) 
Passive congestion of the liver. Central veins, spaces of Disse and 
central vascular sinusoids are dilated, compressing the hepatocytes which 
are atrophied and, with progression, will necrotize - central hemorrhagic 
necrosis (compression and/or ischemic mechanism). Mediolobular 
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hepatocytes may present fatty change (hypoxic mechanism); periportal 
hepatocytes are normal 
 
 
 
If the passive congestion is pronounced, then there can be centrilobular 
necrosis, because the oxygenation in zone 3 of the hepatic lobule is not great. 
The light brown pigment seen here in the necrotic hepatocytes around the 
central vein is lipochrome. 
Congestive hepatopathy is characterized by: 
• Perisinusoidal fibrosis,  
• Hepatic venule dilation, and  
• Dilation of the sinusoids in zone III (centrilobular)    
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Clinical Features of congestive liver disease: 
                          In the mid of 20th century the leading cause of congestive 
cardiac failure leading to liver dysfunction was Rheumatic heart disease 
[67][68], especially, mitral stenosis and tricuspid regurgitation. In the industrial 
world it is the atherosclerotic heart disease the most common cause. 
Hypertensive heart disease is also on the rise. Other causes are as dilated/ 
Restrictive cardiomyopathy congenital heart disease and corpulmonale. 
                         Liver dysfunction in congestive heart failure is usually mild and 
asymptomatic and often detected incidentally on routine liver biochemical 
investigations. The clinical presentation arises mainly from the cardiac disease. 
Some patients may experience right upper quadrant pain secondary to stretching 
of hepatic capsule from an enlarged liver. This symptom may be present in 
acute right- sided heart failure or with exacerbation of chronic heart failure.  
Anorexia, nausea and vomiting may also occur, but it is unclear whether they 
are caused by hepatic congestion, intestinal congestion or other factors such as 
medication, hypoxia or shock.[51]. 
                         Heart failure is rare but reported cause of hepatic 
encephalopathy and coma[67] and hepatic congestion can also cause severe 
hypoglycemia, which may induce stupor[74][75]. Fulminant hepatic failure 
may result from previously unrecognized cardiomyopathy and treatment of 
heart condition may improve liver failure.[76] 
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                            On physical examination jaundice is present in approximately 
20% of patients with congestive liver disease and is dependent on severity of 
heart failure [68]. Of interest, edematous tissue do not appear jaundiced because 
bilirubin is protein bound, and therefore does not enter the edematous areas 
which have a low protein content [77].  
                             Hepatomegaly occurs in 95-99% of patients with moderate to 
severe right heart failure [51][67]. The enlarged liver may be palpated 5 cms 
below costal margin in as many as 50% of patients [73].  
                            Hepatojugular reflex can be elicited by applying manual 
pressure over the liver, which increases venous return to the heart. Because the 
already impaired right heart is unable to accommodate the increased blood flow, 
the resultant back pressure is transmitted to the jugular vein, which is visible on 
physical examination. In the presence of tricuspid regurgitation, a pulsatile liver 
can be palpated. This is the result of transmission of back pressure from the 
regurgitant flow from the hepatic veins [51]. Other etiologies of hepatic 
pulsation in the right sided heart failure include cor-pulmonale and constrictive 
pericarditis. 
                           Peripheral edema is seen in 70-77% of patients with right sided 
failure, pleural effusion in 12-25% of patients but can be as high as 79% in 
patients with cardiac cirrhosis. [51,73] . Ascites is reported in 7 – 49%of 
patients [67][73]. In cardiac ascites protein concentration is usually >2.5g/dl  
and serum ascitic albumin gradient is < 1.1g/dl.[78] 
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                CAUSES OF CARDIAC FAILURE 
Causes of cardiac failure in studies conducted by 2 physicians; in the study of 
liver function abnormalities. 
 White et al Richman et al   ETIOLOGY 
No. of  
patients 
Percentage
(%) 
No. of 
patients 
Percentage
(%) 
Atheroscelerotic HD     12        16      58   33.1 
Hypertensive HD     23       30.7      38   21.7  
Rheumatic HD     33      44.7        56     32 
Cor pulmonale       2       2.7      10    5.7   
Constrictive 
pericarditis 
 
   2 
 
      2.7 
 
     7 
 
    4.0 
Others  
     Congenital         3       1.7 
      Syphilitic     1        1.3        1       0.6 
      Scleroderma           1       0.6 
       Thyroid      2       2.7   
 Ball valve thrombosis        1         0.6 
 
      TOTAL 
 
  75 
 
  100 
 
   175 
 
   100 
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LIVER FUNCTION TESTS IN CARDIAC FAILURE: 
 
SERUM BILIRUBIN: 
                 Congestive heart failure results in abroad range of liver biochemical 
abnormalities. The most common is a mild increase in serum bilirubin levels, 
which occurs inn about 70% of patients [51]. The total serum bilirubin is usually 
less than 3mg/dl with a high unconjugated fraction [51]. However 
strikinglyhyperbilirubinemia may develop in patients with severe usually acute 
right sided heart failure.The exact mechanism of hyperbilirubinemia is unclear 
and multiple factors are thought to contribute,including hepatocellular 
dysfunction, hemolysis,pulmonary infarction secondary to distented hepatic 
veins,medications,superimposed sepsis. 
 
                 S. Sherlock [43] found a correlation of the serum bilirubin level with 
right atrial pressure,not the cardiac output.Therefore,the jaundice of the right 
sided heart failure seems to be clinically and pathophysiologically distinct from 
that associated ischaemic hepatitis and results from congestion rather than 
diminished hepatic perfusion.Upon improvement of the right sided heart failure 
elevated serum bilirubin levels return back to normal quite rapidly over a period 
of 3 to 7 days. 
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  SERUM AMINOTRANSFERASES: 
                      Serum aminotransferases, glutamate dehydrogenase, lactic 
dehydrogenase are all elevated in right sided heart failure [80,73]. Asparate 
transaminase, alanine transaminase rise in up to a third of patients and show, 
similar increases, an increased lactate dehydrogenase is found in 20 to 60% of 
patients.        
                          
 In a series of 175 patients with acute and chronic heart failure 
[ 73] asparate transaminase was elevated in 49% of those with acute heart failure, 
but only in 5% of those with chronic heart failure;80% of the high levels were 
between 40 and 80 I.U. Alanine transaminase results paralleled, but were less 
marked than, those of asparate transaminase. Very high values of asparate 
transaminase (1000-10,000I.U) can occur with an acute onset of severe heart 
failure especially if it is associated with hypotension or shock [43, 72] and they 
correlate well with the degree of centrilobular hepatic necrosis. 
                             Increased venous congestion and decreased hepatic perfusion 
both contribute to the elevation of aminotransferases, although centrilobular 
hypoxia and or necrosis are probably the major factors. 
 
                              The increase in asparate transaminase and alanine 
transaminase and lactate dehydrogenase correlate with increase in systemic 
venous pressure, pulmonary capillary wedge pressure and cardiac index, but the 
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correlation coefficients are low suggesting that other factors must also be 
involved [80 ]                              
                                     Very high enzyme levels in congestive heart failure                    
are often misinterpreted as evidence of viral or drug induced hepatitis [ 81].The 
following clinical features suggest that circulatory failure is the cause of liver cell 
necrosis [82]. 
I. The presence of chronic heart failure 
II. A recent episode of acute circulatory failure 
III. The early appearance of renal insufficiency(this tends to be a late 
development in severe viral hepatitis) 
 
SERUM ALKALINE PHOSPHATASE 
 
                                  Serum alkaline phosphatase rises by about 10-20% in 
patients with congestive cardiac failure [43, 51,73 ]. However in most patients 
the levels are within normal limits; rarely do they exceed twice normal. Elevation 
in serum alkaline phosphatase levels do not correlate with increases in serum 
bilirubin or aminotrnsferases. The highest elevations are usually seen in patients 
with marked liver enlargement. The etiology of abnormal serum level, therefore 
is thought to be a result of intra hepatic obstruction secondary to hepatic 
congestion.[73] . With the improvements in cardiac status, serum alkaline 
phosphatase returns to normal in approximately one week. 
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PROTHROMBIN TIME: 
                                 The prothrombin time is prolonged in 80 – 90% of patients 
with congestive cardiac failure with congestive hepatomegaly and is therefore a 
sensitive index of right-sided heart failure [43,67,73]. Parenteral administration 
of vitamin k results in little or no correction, suggesting that decreased hepatic 
synthesis or decreased activation of vitamin k dependent clotting factors may 
play a role.[67, 73]. Resolution of the prolonged prothrombin time usually takes 
2-3 weeks after successful treatment of the right sided heart failure. Caution 
should therefore be exercised when treating patients in heart patients with 
warfarin or coumarin derivatives [83]. 
 
SERUM PROTEINS: 
                                    Serum albumin is low in about 30-50% of patients with 
congestive hepatomegaly [51, 73]. And the incidence and degree of change 
appears to be similar in acute and chronic failure. The changes were not marked, 
in 75% of those with reduced albumin the values were between 2.5- 2.9gm/dl. 
The lowest values were in patients with right- sided pressures due to rheumatic 
heart disease or cor pulmonale. 
                                   Serum albumin concentrations below 1.5 gm/dl are rarely 
observed and are often associated with marked ascites and edema. The etiologies 
of hypoalbuminea in heart failure include impaired hepatic synthesis, leakage or 
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decreased absorption from the congested intestine and poor nutrition. With the 
resolution of underlying cardiac disease, improvement in serum levels usually 
occurs over a period of few months. The serum albumin levels do not correlate 
with the degree of biological damage to the liver.  
                   
                                   Hyperglobulinemia occurs in 37- 60% of patients with the 
right- sided heart failure, and is more common in patient with acute than with 
chronic heart failure[73]. The elevations tend to be mild with levels between 3.5 
and 4.1 g/dl in the majority of patients. In contrast to other liver tests, the 
hyperglobuminemia usually does not return to normal after treatment of 
congestive heart failure. 
 
                                   Prolonged or recurrent episodes of congestive heart disease  
can lead to cardiac cirrhosis. The incidence is rare, however, most patients die of 
the underlying disease before cirrhosis can develop. 
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MATERIALS AND METHODS 
 
                 All cases of congestive cardiac failure (75), of varied etiologies 
observed in patients from july 2008 - december 2009. 20 healthy individuals 
were taken as controls. Liver function tests are performed to both controls and 
cases, serum bilirubin, AST, ALT, SAP, Serum proteins and Prothrombin time 
admitted at Govt. Royapettah Hospital during the period from july 2008 to both 
on day 1 and day 7 of admission. 
                 This study is an observational study, comparing the liver functions 
between cases (various causes of heart failure) and between cases and controls. 
Cases:   
 Heart failure patients due various etiologies including Coronary heart 
disease, rheumatic heart disease, hypertensive heart disease, cor pulmonale and 
cardiomyopathy meeting the following inclusion criteria and not possessing 
following exclusion criteria were selected 
INCLUSION CRITERIA 
1. Cases of congestive cardiac failure, as per Framingham criteria; of various 
age groups and etiologies such as 
• Rheumatic valvular Heart Disease 
• Ischemic Heart Disease 
• Hypertensive Heart Disease 
• Congenital Heart Disease 
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• Cardiomyopathies 
• Corpulmonale 
 
2. Congestive cardiac failure of varied presentation either acute or chronic. 
 
  EXCLUSION CRITERIA 
1. Known alcoholic 
2. Past History of jaundice 
3. Recent intake of Hepatotoxic drugs or drugs causing raised liver parameters, 
such as Rifampicin, INH, Steroids, chlorpromazine, amiadarone, statins, 
hydralazine , phenytoin and valproate. 
4. positive viral markers 
 
Controls:  
 Healthy individuals between 20-60 yrs of age without any known history of 
medical illness such as heart and liver diseases were selected. 
 
Consent: 
 The study groups thus identified were instructed about the nature of the 
study. Willing participants were taken up after getting a written informed 
consent from them 
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 In this study the following liver functions tests were done: 
1. Serum bilirubin 
2. serum transaminases 
3. serum alkaline phosphatase 
4. serum proteins 
5. prothrombin time. 
         Results were entered in Microsoft Excel Spreadsheet and analyzed. 
Significance values were analyzed using Minitab software, Epi.info software. 
Chi- square test, Student ‘t’ values was applied for significance. Significance was 
considered, if the ‘p’ value was below 0.05. 
 
  SERUM BILIRUBIN 
                        Serum bilirubin was estimated by the vanden bergh reaction. In 
this reaction the bilirubin pigments are diazotized by sulphalinic acid and the 
chromatographic  products are measured calorimetrically. Vanden bergh reaction 
can be used to distinguish between conjugated and unconjugated bilirubin 
because of the different solubility properties of the pigments. When the reaction 
is carried out in an aqueous medium, the water soluble conjugated bilirubin  
reacts to give the direct van den Bergh reaction. When the reaction is carried out 
in ethanol, the intramolecular hydrogen bonds of unconjugated bilirubin are 
broken. Thus both conjugated and unconjugated pigments react giving the total 
bilirubin level. The total minus direct reacting bilirubin gives the indirect value 
which is the measure of unconjugated bilirubin level 
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 SERUM ENZYME ASSAYS 
                 A number of serum enzymes have been used to distinguish and  
assess the cellular injury and biliary tract dysfunction or obstruction. All have 
limitations in sensitivity and specificity and not truly distinguished  
the processes definitely. Elevations in enzyme activities may be                   
hepatic as well as non hepatic disorders like circulatory failure. With  
and careful interpretation, a number of serum enzymes provide important  
clinical tools. 
                     In this study, the serum enzymes namely SGOT and SGPT was  
done by enzymatic substrate method. The substrate used are SGOT and  
SGPT substrate respectively along with D,N,P,H   Di nitro-phenyl hydrannel 
Principle: 
                     These enzyme catalyse the transfer of the gamma amino groups 
 and alanine respectively to the gamma keto group of keto glutamase to the 
formation of oxalo acetic acid and pyruvic acid. 
 
SERUM ALKALINE PHOSPHATASE 
                      Human serum contains several forms of alkaline phosphataseA        
plasma membrane derived enzyme of uncertain physiologic function  
Which hydrolyses acetic phosphate enters at pH 9. A number of different  
assays have been  developed which utilize different substrates. Here the 
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substrate used were Amino-antipyrine solution, potassium ferri cyanide, alkaline 
phosphate buffer and substrate. Elevated levels of  
alkaline phosphatase activity usually reflect impaired biliary tract function. The 
Increased levels reflect increased synthesis of the enzyme by hepatocytes and 
biliary tract epithelium rather than restoration of the enzyme due to obstruction. 
Slight to moderate increased alkaline phosphatase activity can occur secondary to 
congestive cardiac failure. 
SERUM PROTEINS 
                 Extensive liver injury may lead to decreased blood levels of  
albumin, fibrinnogen, prothrombin, and other proteins synthesized exclusively by 
hepayocytes. In contrast to serum enzymes measurements serum protein level 
estimation reflect liver synthetic function rather than hepatocellular injury. Some 
proteins are neither early nor sensitive indicators of liver disease, because of the 
extent of hepatic reserve and their half life. Serum albumin is quantitatively the 
most important serum protein synthesized by the liver. The normal value ranges 
from 3.5 – 5.5 mg/dl. Albumin has a fairly long half life [14 -20 days] with less 
than 5% turnover daily. It is therefore not a good indicator of acute or mild liver 
injury.  
                  Serum globulins are a heterogeneous group of proteins, normally 2.0 – 
3.5 mg /dl includes alpha and beta globulins as well as serum immunoglobulins. 
Varying degree of hyperglobulinaemia reflect increased stimulation of the 
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periphery  reticulo-endothelial compartment due to shunting of antigens passed 
the liver and impaired clearance by hepatic kupffer cells.     
                   Serum proteins were estimated by the Biuret method. In this 
 substances which contain two CO –NH2 groups joined together directly  or 
through a single carbon nitrogen atom and those which contain two    or more 
peptide links   give a blue or purple colored compound with alkaline copper 
solution. The amount of colour given by the biuret reaction also varies 
appreciably for different proteins.        
 
PROTHROMBIN TIME 
               Liver synthesizes six coagulation factors namely Fibrinogen  
[Factor– Prothrombin(Factor–II) and Factors V,VII,IX,X. Abnormalities of these 
coagulation factors can be most efficiently determined by the one stage 
prothrombin time which measures the rate of prothrombin conversion to 
thrombin in the presence of thromboplastin and calcium and requires the   
integrity  of vitamin K dependent coagulation factors. The prothrombin  time is 
dependent on normal hepatic synthesis of clotting factors and sufficient intestinal 
uptake of  vitamin K. Acute or chronic parenchymal liver injury may lead to 
prolongation of the prothrombin time due to impaired synthesis of clotting 
proteins, because these proteins have a shorter half life, the prothrombin time 
may be regarded as an  earlier indicator of severe liver injury and its  elevation in 
both acute or chronic hepatocellular injury serves as an ominous prognostic sign.                      
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RESULTS 
 
 
Table 1 – Sex distribution of cases and controls 
 
 
 
 
controls 
 
cases 
 
  Total 
 
20 
 
74 
 
Male 
 
12 
 
  44 
 
Female 
 
8 
 
31 
 
ratio 
 
1.5:1 
 
1.4:1 
 
 
 
CASES 
female 
41% 
male 
male
59%
 
female 
p value is not significant – 0.914 
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Table -2 Age distribution of cases and controls 
 
             Cases          Controls 
 
Age group 
otal male female Total male femalT
e 
13 -20       1      1      0      0    0     0
21- 30       1      0      1      2    2    0 
31 -40       8      3      5      5    2    3 
41- 50       19       9      10      7    4    3 
51-60       22      17      5      6    4     2 
61-70       15       9      6      0    0    0 
71-80       8       4      4      0    0    0 
81-100       1       1      0      0    0    0 
total       75        44      31     20    12    8 
 
Age distribution
0
5
10
15
20
25
13 -
20
21-
30
31 -
40
41-
50
51-60 61-70 71-80 81-90
age
no
 o
f c
as
es
 a
nd
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on
tr
ol
s
Cases
 controls
 
p value insignificant: 0.0644 
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Table 3- 
Duration of illness 
Years of Heart No of ca es percentage 
 
  
 
 
s
failure 
< 1yr 4 5.3% 
1-5 yrs 33 44% 
>5 yrs 38 50.6% 
 
 
 
 
Duration of illness
< 1yr
1-5 yrs>5 yrs
< 1yr
1-5 yrs
>5 yrs
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Table – 4 
Etiology of heart failure 
 
Etiology       No of cases 
 
Percentage 
 
 
 
 
Rheumatic heart disease 
 
             18 
 
24% 
 
Coronary heart disease 
  
                            30  40% 
 
Cor pulmonale 
  
              13 17.3% 
 
cardiomyopathy 
 
               7 
 
9.3% 
 
Hype ase 
 
             rtensive heart dise
 
               7  9.3% 
 
Rheumatic heart 
disease
24%
Coronary heart 
disease
41%
Cor pulmonale
17%
cardiomyopathy
9%
Hypertensive heart 
disease
9%
Rheumatic heart disease
Coronary heart disease
Cor pulmonale
cardiomyopathy
Hypertensive heart disease
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Table 5  
Percentage of abnormal liver function tests 
   
   
 
 
                                             Cases                  controls
total 75           20 
 
No. with abnormal liver 
function tests 
 
53 
 
            0 
Percentage with abnormal liver 
70.6%  function tests 
  
            0%
 
 
 Percentage of cases with abnormal LFT
71%
29%
No. of cases with Abnormal
liver function tests
No. of cases with normal liver
function tests
 
 
 
 value significant – 0.0003. p
 
 
 
 
 
 
 56
Table 6 
 
Abnormal liver function tests as per etiology 
 
 
  ETIO
abnormal liver 
nction tests 
e LOGY 
 
No. of cases 
 
No. of cases with 
 
  Percentag
fu
R rt 
disease          18      72% 
heumatic hea   
          13     
 
Coronary 
ease 
 
        30          22 
 
       73% Atherosclerotic 
heart dis
  
 
    
 
Cor pulmonale 
 
         13 
 
           9 
 
         69%    
 
Cardiomyopathy 
 
         7 
 
         5 
 
        71%       
 
Hypertensive          7           4         57% 
heart disease 
 
  
 
  
 
  
 
Percentage of ablormal LFT in various causes of CCF.
72% 73% 69% 71%
57%
0%
10%
20%
30%
40%
50%
60%
70%
80%
RH
D
CA
HD
Co
r p
ulm
on
ale
Ca
rdi
om
yo
pa
thy
Hy
pe
rte
nsi
ve
 HD
Percentage of ablormal LFT in
various causes of CCF.
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Table 7 
Clinical Jaundice 
Total no of cases 75 
 
 
Cases with clinical jaun 16 dice 
Percentage of clinical jaundice 21% 
Controls None showed jaundice 
 
 
Ascites 
Total no cases 75 
Table 8 
 
Cases with ascites 6 
Percentage 8% 
Controls N  il
 
 
Table 9 
Hepatomegaly 
 
Total no cases 
 
75 
 
 
 
No of cases with hepatomegaly 
 
51 
 
Percentage 
 
68% 
Controls 0 out of 20 showed hepatomegaly 
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Tab
 
No of cases with hepatomegaly showing increased serum 
alkaline phosphatase 
le 10 
 
 
No of Cases with Hepatomegaly 51 ( out of 75) 
Cases with rais 0 ( out of 75) ed SAP 1
No of cases with raised SAP in 
Hepatomegaly and CCF 
10 ( out 0f 51) 
No of cases with raised ALP without 
hepatomegaly 
0 ( out of 24) 
Percentage of raised SAP in CCF 12.5% 
Percentage of raised SAP in patients 
with CCF having hepatomegaly 
19.6% 
 
 
Hepatomegaly 
without raised 
SAP
hepatomegaly and 
raised SAP
No hepatomegaly 
or raised SAP Hepatomegaly without raised
SAP
hepatomegaly and raised
SAP
No hepatomegaly or raised
SAP
 
                                                                SAP AND HEPATOMEGALY 
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Table 11 
 
Serum bilirubin 
Serum bilirubin No of cases Percentage 
 
< 1.2 (Normal) 29.3% 22 
1.2 – 3 mg% 43 57.3% 
3-5 mg% 7 9.3% 
>5 mg% 3 4% 
 
 
Serum bilirubin
< 1.2 (Normal)
1.2 – 3 mg%
3-5 mg%
>5 mg%
< 1.2 (Normal)
1.2 – 3 mg%
3-5 mg%
>5 mg%
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Table 12 
Serum bilirubin with remission and exacerbation 
No
exacerbation) 
 
 
 
 of cases with abnormal LFT 53 ( On follow up, 47 showed 
remission; 6 showed 
No of cases showing exacerbation 6 
No of cases showing increase of 
Serum bilirubin on exacerbation 
4,    2- no change 
 
                     Percentage  66.6% 
No of cases showing remission 47 
No of cases showing reduction of 44;  3- showed increase 
Serum biliruubin on remission 
Percentage 93.6% 
Controls  Serum bilirubin were normal in 
all the controls 
 
 
 
- value is significant – 0.0212. 
 
p
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Table 13 
Liver function tests 
RESULTS 
 
 
S 
No 
Test Normal 
Ran  of percentagege Range No
patients 
< 1.2 22 29.3% 
1.2-3 57.3% 
mg/dl 
43 
3-5 mg/dl 9.3% 7 
1. Serum
biliru
 
bin 
/dl 
0-3-1.2 
mg/dl 
>5 mg 3 4% 
Norma
range 
l 36 48% 2. 0 I.U 
 
AST Upto 4
Increased 39 52% 
Normal 
range 
44 58.6% 3. ALT Upto 35 I.U 
Increased 31 41.3% 
Normal 
range 
65 86.6% 4. S.A.P 3 – 13 KA 
ed 10 13.3% 
Units 
Increas
Normal 57 76% 
Reduced 15 20% 
5. Serum albumin   >3g% 
3 4% 
 
A:G 
reversal 
Normal 33 44% 6. Prothrombin 
time 
( 12-
4 sec), Test 
abnormal if  
1 ½  times d 42 56% 
Control 
1
greater than 
control 
Prolonge
 
   In controls, no abnorm a
 
ality of LFT w s noted. 
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                                      DISCUSSION 
         A lot of research has been done in assessing liver function in congestive 
ue to various etiologies in 75 patients have been compared within 
 
                                                                                              
           Hepatomegaly was seen in 51 patients out of 75 (68%). The liver 
ac 
 et 
            Icterus was present in 16(21%) cases. Alcohol induced jaundice and 
 due to hepatotoxic drugs were ruled out by relevant history taking. Viral 
cardiac failure 
         In this study, the clinical features and liver function test in congestive 
cardiac failure d
and with 20 controls and correlated with various studies in an effort to compare 
Indian scenario with global picture. 
Hepatomegaly                                  
enlargement varies from 1cm to 10cm below the RCM in 26% of cases. White et al 
(1956)[67] found hepatomegaly in 95% of their cases of congestive cardi
failure and Sinha (1960)[84] found hepatic enlargement in 25.5% of cases. Dunn 
et al (1973)[51] have also described hepatomegaly in 95% of cases. Richman
al (1961)[73] have described hepatomegaly more than 5cm in as many as 50% of 
patients. None of the controls did have hepatomegaly. 
 
Icterus 
  
jaundice
hepatitis was ruled out by serological tests for viral markers. Rheumatic heart 
disease produced the most number of cases with clinically detectable jaundice. 
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Icterus was least present in patients with Cor pulmonale and hypertensive hear
disease. None of the controls had icterus. 
                 White et al [67] have reported clinically apparent jaundice in 20% of 
cases. Gravin et al [25] and Kubo et al [80
t 
] have also described clinical jaundice 
 
                     Hyperbilirubinemia was detected in 53 out of 75 cases. The 
ted with hyperbilirubinemia were coronary artery heart 
ases 
n 
ardiac failure; it rarely exceeds 5mg/d land 
 
eported 
 
in less than 20% of cases. 
Hyperbilirubinemia 
etiologies most associa
disease (73%) and rheumatic valvular heart disease(72%).In majority of c
serum bilirubin did not exceed 3mg/dl. 
                         Kubo et al [80] have reported that serum bilirubin is increased i
20 to 80% of patients with congestive c
is usually less than 3mg/dl. Zieve [85] has reported that unconjugated bilirubin is 
usually higher than conjugated bilirubin. Sherlock [43]and Richman et al 
[73]have also reported that levels usually range     between 1mg/dl  and 5mg/dl with
the unconjugated form constituting the major fraction. Sherlock [43] has r
that only rarely have levels exceeded 20 mg/dl in patients with severe right-sided 
heart failure. Richman et al [73]has observed that with improvement of the right-
sided heart failure elevated serum bilirubin levels return back to normal quite 
rapidly over a period of 3-7 days. 
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% of cases with hyper 
bilirubinemia 
S. NO Authors 
1 Felder et al 52% 
2 Sherlock 68% 
3 Evans et al 26% 
4 White et al 40% 
5 Wahi et al 45% 
6 Naresh bhu 58% 
7 Richman et al 31% 
8 This study 70.6% 
 
    arked increase in s was observe heumatic valvular 
he  disease in this stu relates with Sh  [43] observation 
that the deep icterus has a correlation with valvular diseases of heart. The 
n 
 
lure. 
 
M erum bilirubin d in r
art dy. This cor erlock’s
severity of failure and duration of failure correlate well with the elevation i
serum bilirubin level. The elevated bilirubin level was less than 3mg/dl in 43
cases and more than 5mg/dlin 3 cases who had severe congestive cardiac fai
With remission of congestive cardiac failure, the serum bilirubin returned to 
normal in 47 cases which correlates with Richman et al [73].   
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  n 
le g/dl ; which 
orrelates with Kubo’s [80] observation.                  
1] and Sherlock et al [43] 
have reported that elevation in serum aminotransferase levels are seen in 3-50% 
eart failure. The wide range in incidence reflects the 
 
minase levels, the former values 
nging from 40-801I.U.This degree of marked elevation is seen in acute heart 
. 
e 
5 
U. which correlate with Richman’s [73] observation. 
 
   In this study 71% of patients showed an abnormal increase in serum bilirubi
vels of which 81% showed mild rise of bilirubin between 1-5m
c
 
Serum aminotransferases 
                               Richman et al [73], Dunn et al [5
of patients with right sided h
fact that elevations are seen more commonly in acute congestive heart failure 
(15-48%) than in chronic failure (3-5%). 
 
                               Richman has reported that asparate transaminase levels are
typically more marked than alanine transa
ra
failure secondary to cor pulmonale or rheumatic heart disease with tricuspid 
insufficiency, or due to heart failure complicated by shock and hypertension
 
                                In the present study one patient who had severe congestiv
cardiac failure with shock, showed elevation of asparate transaminase upto 92
I.
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                                In the present study 39 cases (52%) of cases showed elevate
asparate transaminase  levels and 31 cases (41%) of alanine transaminase levels.
                                With remission 72% of raised aspar
d 
 
ate transaminase levels 
nd 74% raised alanine transaminase levels returned to normal. 
 
 
right sided heart 
failure. Dunn et al [51] however reports that in most patients the levels are within 
eed twice normal. Felders et al [86] have also 
are 
ent in 
line phosohatase returns to normal in 1 week. 
ch 
al. 
a
Serum alkaline phosphatase  
                              Richman et al [73] and Sherlock [43] have reported elevation
of serum alkaline phosphatase levels in 10-20% of patients with 
normal limits,rarely do they exc
reported increased serum alkaline phosphatase in 10-20% of patients with 
congestive cardiac failure.   
                            Elevation of serum alkaline phosphatase levels do not correlate 
with increases in serum bilirubin or aminotransferases. The highest elevations 
usually seen in patients with marked liver enlargement [73].With improvem
the cardiac status serum alka
                             In the present study 10 cases (13%) showed elevation in 
alkaline phosphatase levels. With remission, in all cases the serum alkaline 
phosphatase levels returned to normal. In 51% of cases that had 
hepatomegaly,20% showed elevated serum alkaline phosphatase levels whi
correlates with Richman et al’s [73] study. In controls, the values were norm
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Serum Proteins:  
                 The serum albumin was decreased in 30-50% of patients with 
congestive cardiac failure as per Richman et al [73]. 
                 The degree of hypoalbuminemia was usually mild and the majority of 
els between 2.5and 2.9 g/dl. Dunn et al [51] reported that 
often 
lution of the underlying 
n 3.5 and 4.1 g/dl in the majority of patients. In contrast to other 
 
 
ering a 
in globulin and hypoalbuminemia were associated with a poor prognosis.  
 
patients exhibit lev
serum albumin concentrations below 1.5 g/dl are rarely observed and are 
associated with marked ascites and edema. With reso
cardiac disease, improvement in serum albumin usually occurs over a period of a 
few months. 
                 According to Richman et al [73],hyperglobuminemia occurs in 37-
50% of patients with right sided heart failure and is more common in patients 
with acute than with chronic heart failure. The elevation tends to be mild, with 
levels betwee
liver tests, the hyperglobulinemia usually does not return to normal after 
successful treatment of the congestive cardiac failure. The increase in globulin
levels and the decrease in albumin levels lead to reversal of Alubumin/Globulin
ratio. 
                 In the present study15 cases showed decreased albumin (consid
cutoff 3mg%) ; 3 cases showed increased globulin. Albumin globulin reversal 
was noted in 3 cases. On remission one patient turned normal. Presence of 
album
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ith 
and Dunn et al [51] report that the prothrombin time returns to normal usually 2 
to 3 weeks following the successful treatment of heart failure. In the present 
 cases studied showed a prolonged prothrombin time. The 
e 
7 
  
 
 
 
 
Prothrombin time: 
                                 Prothrombin time is prolonged in 80-90% of patients w
acute and chronic heart failure according to White et al [67].Richman et al [73] 
study 42 of 75 (56%)
prolongation in the prothrombin time ranged from 11/2 times to 2 times that of th
control. Controls did not show any variation. Repeated prothrombin time at day 
did not show any improvement on remission. As the prothrombin time could not 
be repeated at 3 weeks from remission changes might not have occurred; as 
suggested by other studies. 
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SUMMARY 
                         In this study done at Govt. Royapettah Hospital; 75 patients with 
congestive cardiac failure of varied etiologies were studied. The grades of 
severity also varied. The liver function tests of these patients were evaluated by 
measuring the serum bilirubin, Serum transaminases, Serum alkaline phosphatase, 
serum proteins and prothrombin unctions were evaluated at 
d 
and 80 
e 21 -30, 5 were between 
nts. 
 
 time. The above f
admission and at the seventh day of admission. The clinical progression was also 
noted as remission or exacerbation. 20 controls were chosen from healthy 
individuals of the hospital; 12 were male and 8 female. 
                            Of these 75 patients studied, 44 were male and 31 were female. 
Of these 1 was between age of 20, 1 between 21 and 30, 8 were between 31 an
40, 19 were between the ages of 41 and 50, 22 were between the ages of 51 and 
60, 15 were between the ages of 61 and 70, 8 were between the ages of 71 
and 1 was >80.  Among controls, 2 were between the ag
the age 31 – 40; 7 were between the age 41-50 and 6 were above 51. 
                             The duration of cardiac failure was more than 5 years in 38 
patients, between 1-5 years in 33 patients and less than 1 year in 4.The etiology 
of congestive cardiac failure was rheumatic valvular heart disease in 18 patients, 
cor pulmonale in 13 patients, coronary artery heart disease in 30 patients, 
hypertensive heart disease in 7 patients and cardiomyopathy in 7 patie
 70
                             Clinically apparent jaundice was seen in 16 patients, 
Hepatomegaly was seen in 52 patients, Ascites was present in 6 patients.   Of the
53 patients whose liver functions were deranged,47 attained remission of heart 
failure and 6 cases showed exacerbation of heart failure. 
                             Analysis of the liver tests showed hyperbilirubinemia in 
 
53 
patients, Of these 10 patients had bilirubin more than 3mg. Asparate 
creased 
in 
 42 patients. 
 disease 
t 
atients 
le 9 
with cardiomyopathy showed abnormal liver function.      
 
transaminase was increased in 39 cases and alanine transaminase was in
in 31 cases. Alkaline phosphatase was increased in 10 cases and serum proteins 
were abnormal in 15 cases with reversal of A/G ratio in 3 cases. The prothromb
time showed prolongation more than 1 ½ times normal in
                              Analysis according to the various Etiologies shows that 
patients with coronary artery heart disease (73%) and rheumatic heart
(72%) showed the most percentage of abnormal liver function tests and patients 
with hypertensive heart disease (57%) showed least percentage of abnormal hear
failure. 
                              Of the 18 patients with rheumatic heart disease,13 p
showed abnormal liver function (72%), Of the 13 patients with cor pulmona
showed abnormal liver function (69%). In 7 patients with hypertensive heart 
disease 4 showed abnormal liver function (57%), whereas in 30 patients with 
coronary artery heart disease,22 showed abnormal liver function (73%) 5 out of 7 
patients 
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Severity of cardiac failure 
                     Serum bilirubin more than 3mg/dl was present with severe 
congestive cardiac failure. Gross elevation of transaminases was present in se
congestive cardiac failure with hypotension and shock. Hypoalbuminemia and
albumin-globulin ratio reversal were found in chronic congestive cardiac failure 
and were associated with poor prognosis. 
vere 
 
eved 
xacerbation 
Exacerbation of congestive cardiac failure was seen in 6 cases. With 
as 
 
 
Remission 
                    Of the 53 patients with abnormal liver function tests, 47 achi
remission from congestive cardiac failure within 7 days. With remission the 
hyperbilirubinemia, and the increased asparate transaminase levels and alanine 
transaminases levels returned to normal. The prothrombin time and serum 
proteins did not show any marked change 
E
                   
exacerbation, elevation of serum bilirubin, asparate transaminase, alanine 
transaminase, alkaline phosphatase and prothrombin time was noted. There w
no change in serum proteins.                               
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CONCLUSION 
1. The commonest aetiology of cases presenting with features of conges
cardiac failure at Government Royapettah Hospital is coronary artery heart 
disease. 
tive 
 Liver function abnormalities were mostly present in patients with coronary 
rtery disease (73%) and rheumatic valvular heart disease (72%) developing heart 
ilure. 
3. Liver function abnormalities were least in patient with hypertensive heart 
disease (57%) developing hea
 
n 
not change with remission. 
ere congestive cardiac failure with hypotension leads to a gross elevation 
n correlated with the presence of 
lin ratio reversal were associated with a 
2.
a
fa
rt failure. 
4. The serum bilirubin, serum alkaline phosphatase and serum transaminases
returned to normal with remission. Serum protein values and the prothrombi
time did 
5. The serum bilirubin, serum enzymes and prothrombin time were elevated 
with exacerbation. Serum proteins did not show any change with exacerbation. 
6. Sev
of serum asparate transaminase and alanine transaminase. 
7. Serum alkaline phosphatase elevatio
hepatomegaly. 
8. Serum bilirubin levels at presentation of more than 5mg, presence of 
hypoalbuminemia and albumin-globu
poor prognosis. 
 x
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PROFORMA 
 
Name                                                                      : 
 
Age / sex                                                                 : 
 
M R D  No                                                              : 
 
Presenting Complaints                                            : 
         Chest Pain                                                      :  Duration  : 
         Breathlessness                                                :  
         PND / Orthoonnoea                                        : 
         Cough / Expectoration                                    : 
         Haemoptysis                                                   : 
         Pedal Oedema                                                 : 
         Oliguria                                                           : 
         Fever                                                               : 
         Syncope                                                          : 
         Other Symptoms                                             : 
 
Past H/o                                  Diabetes –                           Duration 
Hypertension 
                                                     IHD 
       Bronchial Asthma 
                                                      Jaundice 
      Rheumatic Fever 
Tuberculosis 
      Similar Episodes 
                                                     TIA 
       Exposure to STD 
 
    Personal H/o                                                             :   Smoker 
                                                                                     Alcoholic 
 
    Family H/o                                                               :   Hypertension 
                                                                                    Diabetes 
                                                                                    IHD 
 
 
 ii
 
General Examination                                                Consciousness 
                                                                                      Orientation 
                                                                                      Temperature 
                                                                                      Anemia 
                                                                                      Jaundice 
                                                                                      Cyanosis 
                                                                                      Clubbing 
                                                                                      Pedal edema 
                                                                                      Lymphadenopathy 
                                                                                     JVP 
                                                                                     Peripheral signs of  
                                                                                   Infective endocarditis 
                                                                                      Peripheral signs of 
                                                                                    Cirrhosis liver 
 
                                                                                   Vital Parameters 
 
                                                                                    Pulse rate 
                                                                                    Blood pressure 
                                                                                    Respiratory rate 
 
CARDIOVASCULAR SYSTEM                             Heart Sounds 
                                                                                   Murmurs 
                                                                                   Added Sounds 
                                                                                   Parasternal Heave 
                                                                                   Abnormal Pulsations 
 
RESPIRATORY SYSTEM                                      Rate 
                                                                                  Accessory muscle 
                                                                                  Air entry 
                                                                                  Rales/ Rhonchi 
 
ABDOMEN                                                              Appearance 
                                                                                  Ascites 
                                                                                  
                                                                                  Hepatomegaly- 
                                                                                           Liver span 
                                                                                           Tenderness 
                                                                                            Consistency 
                            
                                                          Spleenomegaly 
 iii
 
CENTRAL NERVOUS SYSTEM 
                                                                                 Higher Functions 
                                                                                 Cranial Nerves 
                                                                                 Motor System  
                                                                                 Sensory System 
                                                                                 Cerebellum 
                                                                                 Spine&Cranium 
                                                                                 Others 
 
DIAGNOSIS 
     Onset of illness                                                        Acute  
                                                                                     Chronic 
                                                                                     Acute on chronic     
 
     Duration of illness                                                   < 1 Year 
                                                                                          1-5 Years 
                                                                                      >  5 Years 
 
 
 
    Investigations 
 
1. Urine routine 
2. Hb 
3. Tc,Dc,ESR 
4. Urea 
5. Creatintine 
6. Electrolytes 
7. Sugar 
8. V D R L 
9. HbsAG / ANTI HCV  
10. ECG 
11. X-Ray Chest 
12. Echocardiogram 
 
 
 
 
 
 
 iv
 
13. LIVER FUNCTION TESTS: 
 
 
             SGOT 
             SGPT 
            Alkaline Phosphatase 
            GGT 
            S.Bilirubin- Total 
                                Direct 
                                Indirect 
            Total Proteins 
            Albumin 
            Globulin  
            AG ratio 
            Prothrombin time 
 
14. USG abdomen 
 
15. Biopsy in selected patients     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormalities of liver function tests 
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 v
 
 
 vi
 
 
 
 vii
 
 
 viii
 
 
 ix
 
 
 
